Find your favorite nonprofit or choose one that inspires you from our database of over 2 million charitable organizations.
Displaying 73–84 of 3,433
The National Pediatric Cancer Foundation (NPCF) is a nonprofit organization dedicated to funding and developing novel research and clinical trials to find less toxic, more effective treatments for childhood cancer. Our purpose is to reduce the side effects of current treatments, improve survival rates, and ultimately eliminate childhood cancer. NPCF is a nonprofit organization under section 501(c)(3) of the Internal Revenue Code. At the National Pediatric Cancer Foundation, we are aggressively pursuing measurable change in how pediatric cancer research is approached and funded through our collaborative research consortium, the Sunshine Project. The Sunshine Project’s one-of-a-kind research model focuses on translational studies and phase 0, 1, and 2 clinical trials that address a multitude of different pediatric cancers. Our innovative approach capitalizes on the strengths of researchers from various scientific fields throughout the country, streamlining the protocol development process to deliver more personalized medicine to children with cancer. This utilization of scientific and philanthropic partnerships allows us to fast-track potential new therapies with less toxicity into clinical trials. The treatment options currently being discovered bring great promise for children who have not experienced positive results under the standard treatment protocol.
A 501(c)(3) nonprofit organization raising awareness and funds for new global, cutting-edge research to find a cure for glioblastoma. The purpose of the Glioblastoma Research Organization is to provide financial support to doctors and researchers around the world, that are working on developing cutting-edge technologies and clinical trials through research, to increase the rate of survival in patients, and find a cure for this disease.
Founded in 1990, the International Myeloma Foundation (IMF) is the oldest and largest myeloma-specific charity in the world. With more that 350,000 members in 140 countries, the IMF serves myeloma patients, family members, and the medical community. The IMF provides a wide range of programs in the areas of Research, Education, Support and Advocacy.
Gilda's Club Madison creates a community of free emotional support, cancer education, and hope for children and adults with any cancer diagnosis and those who care for them.
We are a nearly 60 year old cancer organization. Our mission is to educate, support, and empower those diagnosed with Cancer. We provide independent information and research to enable patients and their families to make smarter choices for treatment with an emphasis on cure, functionality and dignity. Our goal is to save more lives. Educate. Navigate. Research. Empowerment. 92 cents of every dollar donated allows us to support all those fighting cancer. Your generous donation, to honor the living, remember someone who passed, or a general donation, supports patient research, cancer education, prevention, and disease navigation. Make your tax-deductible donation today and together we can help save more lives.
The Multiple Myeloma Research Foundation, Inc. mission is to: relentlessly pursue innovative means that accelerate the development of next-generation multiple myeloma treatments to extend the lives of patients and lead to a cure. To achieve this purpose, four goals are pursued: Funding research in the field of multiple myeloma, building collaborations among researchers and industry, providing disease and treatment related information to patients and family members while advocating for optimal patient care, and raising awareness of multiple myeloma.
From the website: "American Lebanese Syrian Associated Charities (ALSAC) was founded by Danny Thomas in 1957 to be the fundraising and awareness organization for St. Jude Children’s Research Hospital, and its sole mission is to raise the funds and awareness necessary to operate and maintain the hospital. In the years ahead, an estimated 89% of the funds necessary to sustain and grow St. Jude must be raised by ALSAC from generous donors."
The NPCF (founded May 2009) strives to provide quality of life, sustainability and dignity to those we serve. Through our volunteers we provide an opportunity of hope and caring for those afflicted by this devastating disease. We also provide the opportunity for their family members to help fight one of the leading causes of cancer deaths in the United States. There is no known cure, however, there are new developments everyday to prolong and sustain the quality of life of the patient.
To maximize dollars available for Roswell Park Comprehensive Cancer Center's most promising lifesaving research, treatment and prevention programs, while supporting the psychosocial needs of patients and families touched by cancer. Fundraising events and initiatives are carried out through a partnership between committed Roswell Park Alliance volunteers and Foundation staff.
The LIVESTRONG Foundation fights to improve the lives of people affected by cancer now. Created in 1997, the Foundation is known for leading an ongoing dialogue with patients and survivors, providing free cancer support services and advocating for policies that improve access to care and quality of life. Known for its powerful brand – LIVESTRONG – the Foundation has become a symbol of hope and inspiration around the world. Since its inception, the Foundation has served 2.5 million people affected by the disease and raised more than $500 million to support cancer survivors. One of America's top non-profit organizations, the Foundation enjoys a three-star rating from Charity Navigator and has been recognized by the National Health Council and the Better Business Bureau for its excellent governance, high standards and transparency. For more information, visit LIVESTRONG.org.
TargetCancer Foundation promotes the development of lifesaving treatment protocols for rare cancers. TargetCancer Foundation directly supports initiatives at the forefront of cancer treatment by funding innovative research, fostering collaborations, and raising awareness among scientists, clinicians, and patients.